SCO-272
- Generic Name
- SCO-272
Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or Midazolam
Phase 1
Completed
- Conditions
- Japanese Healthy Adult Males
- Interventions
- First Posted Date
- 2015-02-25
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- Takeda
- Target Recruit Count
- 34
- Registration Number
- NCT02370615
Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment
- First Posted Date
- 2015-02-20
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Takeda
- Target Recruit Count
- 48
- Registration Number
- NCT02367872
A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria
Phase 2
Completed
- Conditions
- Type 2 Diabetes Mellitus and Microalbuminuria
- Interventions
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2018-08-13
- Lead Sponsor
- Takeda
- Target Recruit Count
- 415
- Registration Number
- NCT02332824
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath